[Retracted] Antidiabetic Effect of Tamarindus indica and Momordica charantia and Downregulation of TET-1 Gene Expression by Saroglitazar in Glucose Feed Adipocytes and Their Involvement in the Type 2 Diabetes-Associated Inflammation In Vitro

Table 3

In streptozotocin-induced diabetic male albino rats with liver and kidney GOT and GPT activities, aqueous seed extracts of Tamarindus indica and Momordica charantia (mean ± S.D.) were compared to their aqueous seed extracts after 7 days and 14 days.

Group	GOT (unit/ml)	GPT (unit/ml)
Control (7 days)	14.6 ± 0.5	11.7 ± 0.6
Diabetic (7 days)	23.2 ± 0.6	20.0 ± 0.9
Tamarindus indica supplement (7 days)	19.1 ± 0.6	17.0 ± 0.6
Momordica charantia supplement (7 days)	19.4 ± 0.5	17.2 ± 0.5
Control (14 days)	14.1 ± 0.6	12.3 ± 0.8
Diabetic (14 days)	26.4 ± 0.5	23.4 ± 0.4
Tamarindus indica supplement (14 days)	14.2 ± 0.4	12.1 ± 0.3
Momordica charantia supplement (14 days)	14.6 ± 0.5	12.5 ± 0.6

ANOVA followed by multiple two-tailed -tests. Within each vertical column, () indicates that means differed from one another as well as from controls (). Nonasterisk figures do not differ significantly from one another in each vertical column () within the same duration of treatment.